Nanotechnology Now - News Story: pSivida Limited: Despatch of Rights Issue Prospectus

Home > News > pSivida Limited: Despatch of Rights Issue Prospectus

May 24th, 2006

pSivida Limited: Despatch of Rights Issue Prospectus

Abstract:
Global bio-nanotech company pSivida Limited (ASX:PSD)(NASDAQ:PSDV)(Xetra:PSI) today confirmed that the despatch to eligible shareholders of the Rights Issue prospectus and entitlement and acceptance forms was completed today.

Source:
businesswire

Bookmark:

Related News Press

Announcements

Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025

Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025

Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025

ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE